SKOPJE (North Macedonia), May 19 (SeeNews) - North Macedonia-based drug maker Replek [MSE:REPL] said that its non-consolidated net profit grew 32% on the year to 110.7 million denars ($1.9 million/1.8 million euro) in the first quarter of 2020, backed by higher revenue.